KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Accumulated Expenses (2016 - 2026)

Pfizer has reported Accumulated Expenses over the past 18 years, most recently at $2.7 billion for Q1 2026.

  • Quarterly Accumulated Expenses rose 4.14% to $2.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.7 billion through Mar 2026, up 4.14% year-over-year, with the annual reading at $3.6 billion for FY2025, 5.94% down from the prior year.
  • Accumulated Expenses was $2.7 billion for Q1 2026 at Pfizer, down from $3.6 billion in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $3.8 billion in Q4 2024 and troughed at $2.0 billion in Q3 2023.
  • The 5-year median for Accumulated Expenses is $2.6 billion (2025), against an average of $2.7 billion.
  • Year-over-year, Accumulated Expenses dropped 18.52% in 2023 and then surged 42.62% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $3.4 billion in 2022, then fell by 18.52% to $2.8 billion in 2023, then surged by 38.26% to $3.8 billion in 2024, then decreased by 5.94% to $3.6 billion in 2025, then decreased by 24.79% to $2.7 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Accumulated Expenses are $2.7 billion (Q1 2026), $3.6 billion (Q4 2025), and $3.0 billion (Q3 2025).